Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Showing 20 of 0 results

Not applicableStudy completedNCT03051958
What this trial is testing

Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Karolinska Institutet 102
Testing effectiveness (Phase 2)WithdrawnNCT03464526
What this trial is testing

The Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Nerre Therapeutics Ltd.
Not applicableStudy completedNCT02401178
What this trial is testing

The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants

Who this might be right for
Atopic Dermatitis
Universitas Indonesia 400
Testing effectiveness (Phase 2)Study completedNCT02068352
What this trial is testing

Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Otsuka Pharmaceutical Development & Commercialization, Inc. 121
Large-scale testing (Phase 3)Study completedNCT03131648
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 802
Early research (Phase 1)Not Yet RecruitingNCT07746817
What this trial is testing

BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy Participants
Bionyra Pharma 56
Testing effectiveness (Phase 2)Study completedNCT05613062
What this trial is testing

Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children

Who this might be right for
Atopic Dermatitis
Chinese University of Hong Kong 20
Not applicableLooking for participantsNCT07544862
What this trial is testing

Stapokibart Injection in Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Chengdu Kangnuoxing Biopharma,Inc. 1,000
Testing effectiveness (Phase 2)Study completedNCT00931242
What this trial is testing

Study of Apremilast in Atopic or Contact Dermatitis

Who this might be right for
Atopic DermatitisAllergic Contact Dermatitis
Tufts Medical Center 10
Not applicableActive Not RecruitingNCT06169527
What this trial is testing

A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

Who this might be right for
Atopic Dermatitis
Sanofi 303
Not applicableUnknownNCT05598762
What this trial is testing

The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape Strips

Who this might be right for
Atopic Dermatitis
Queen Sirikit National Institute of Child Health 100
Testing effectiveness (Phase 2)Study completedNCT02001181
What this trial is testing

Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

Who this might be right for
Dermatitis, Atopic
Pfizer 69
Testing effectiveness (Phase 2)Study completedNCT05870865
What this trial is testing

Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicPruritus
Formation Bio, Inc. 144
Large-scale testing (Phase 3)Study completedNCT05724199
What this trial is testing

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 746
Large-scale testing (Phase 3)Study completedNCT05372419
What this trial is testing

(LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 90
Not applicableStudy completedNCT01660217
What this trial is testing

Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management

Who this might be right for
Atopic Dermatitis
Dermatology & Aesthetics of Wicker Park 37
Not applicableUnknownNCT04449575
What this trial is testing

Hand Eczema in the Health Care Sector

Who this might be right for
Hand Eczema
University Hospital Bispebjerg and Frederiksberg 300
Not applicableStudy completedNCT01569906
What this trial is testing

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Who this might be right for
Moderate to Severe Atopic Eczema
Royal Victoria Infirmary 58
Not applicableStudy completedNCT02906475
What this trial is testing

Atopic Dermatitis in Atopy Predisposed Infants

Who this might be right for
Dermatitis, Atopic
HiPP GmbH & Co. Vertrieb KG 160
Large-scale testing (Phase 3)Study completedNCT03346434
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 202
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation